Astrana Health Files Q3 2024 10-Q

TL;DR

Astrana Health's Q3 2024 10-Q is in. Check financials and segment performance.

AI Summary

Astrana Health, Inc. filed its 10-Q for the period ending September 30, 2024. The filing details financial performance and operational updates for the third quarter. Key financial data and disclosures related to its business segments and related party transactions are included.

Why It Matters

This filing provides investors and analysts with the latest financial health and operational status of Astrana Health, Inc., crucial for understanding its market position and future prospects.

Risk Assessment

Risk Level: medium — The filing is a standard quarterly report, but the nature of the healthcare industry and potential regulatory changes can introduce medium-level risks.

Key Numbers

• 2024-09-30 — Reporting Period End Date (Indicates the end of the fiscal quarter for which financial information is reported.)
• 2024-11-12 — Filing Date (The date the 10-Q was officially submitted to the SEC.)

Key Players & Entities

• Astrana Health, Inc. (company) — Filer of the 10-Q
• 2024-09-30 (date) — End of the reporting period
• Apollo Medical Holdings, Inc. (company) — Former company name
• 8742 (number) — Standard Industrial Classification Code for Management Consulting Services

FAQ

Key Financial Figures

• $0.001 — nge on Which Registered Common Stock, $0.001 par value per share ASTH The Nasdaq

Filing Documents

• asth-20240930.htm (10-Q) — 4289KB
• asth-ex10_3.htm (EX-10.3) — 47KB
• asth-ex31_1.htm (EX-31.1) — 16KB
• asth-ex31_2.htm (EX-31.2) — 15KB
• asth-ex32.htm (EX-32) — 12KB
• asth-ex99_1.htm (EX-99.1) — 73KB
• img123525869_0.jpg (GRAPHIC) — 35KB
• 0000950170-24-125133.txt ( ) — 18977KB
• asth-20240930.xsd (EX-101.SCH) — 1993KB
• asth-20240930_htm.xml (XML) — 4535KB

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 48 Item 3.

Quantitative and Qualitative Disclosures about Market Risk

Quantitative and Qualitative Disclosures about Market Risk 63 Item 4.

Controls and Procedures

Controls and Procedures 63 PART II OTHER INFORMATION Item 1.

Legal Proceedings

Legal Proceedings 64 Item 1A.

Risk Factors

Risk Factors 64 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 67 Item 3. Defaults Upon Senior Securities 67 Item 4. Mine Safety Disclosures 67 Item 5. Other Information 68 Item 6. Exhibits 69 2 Glossary The following abbreviations or acronyms that may be used in this document shall have the adjacent meanings set forth below: AAMG All-American Medical Group ACO REACH ACO Realizing Equity, Access, and Community Health ADSC Advanced Diagnostic and Surgical Center, Inc. AHMC AHMC Healthcare Inc. AHMS Advanced Health Management Systems, L.P. AHM Astrana Health Management, Inc. (f/k/a Network Medical Management Inc.) APAACO APA ACO, Inc. APC Allied Physicians of California, a Professional Medical Corporation APC-LSMA APC-LSMA Designated Shareholder Medical Corporation Astrana Astrana Health Inc. (f/k/a Apollo Medical Holdings, Inc.) Astrana Medical Astrana Health Medical Corporation (f/k/a AP-AMH Medical Corporation) Astrana Care Partners Medical Astrana Care Partners Medical Corporation (f/k/a AP - AMH 2 Medical Corporation) CAIPA MSO CAIPA MSO, LLC CFC Community Family Care Medical Group IPA, Inc. CMS Centers for Medicare & Medicaid Services DMHC California Department of Managed Health Care DMG Diagnostic Medical Group of Southern California HSMSO Health Source MSO Inc., a California corporation IPA Independent Practice Association Jade Jade Health Care Medical Group, Inc. LMA LaSalle Medical Associates PCCCV Primary Community Care of Central Valley, Inc. PMIOC Pacific Medical Imaging and Oncology Center, Inc. Sun Labs Sun Clinical Labs VIE Variable Interest Entity 3 INTRODUC TORY NOTE Unless the context dictates otherwise, references in this Quarterly Report on Form 10-Q to the "Company," "we," "us," "our," and similar words are references to Astrana Health, Inc., a Delaware corporation ("Astrana"), and it

- FINA NCIAL INFORMATION

PART I - FINA NCIAL INFORMATION

CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

ITEM 1. CONDENSED CONSOLIDATED FINANCIAL STATEMENTS ASTRANA HEALTH, INC. CONDENSED CONSOLIDATE D BALANCE SHEETS (IN THOUSANDS, EXCEPT SHARE AND PER SHARE DATA) September 30, 2024 December 31, 2023 (Unaudited) Assets Current assets Cash and cash equivalents $ 347,994 $ 293,807 Investment in marketable securities 2,354 2,498 Receivables, net 132,237 76,780 Receivables, net – related parties 76,568 58,980 Income taxes receivable 16,211 10,657 Other receivables 1,120 1,335 Prepaid expenses and other current assets 20,506 17,450 Total current assets 596,990 461,507 Non-current assets Land, property, and equipment, net 12,172 7,171 Intangible assets, net 109,108 71,648 Goodwill 409,711 278,831 Income taxes receivable 15,943 15,943 Loans receivable, non-current 55,284 26,473 Investments in other entities – equity method 34,629 25,774 Investments in privately held entities 8,896 6,396 Restricted cash 646 345 Operating lease right-of-use assets 33,119 37,396 Other assets 8,878 1,877 Total non-current assets 688,386 471,854 Total assets (1) $ 1,285,376 $ 933,361 Liabilities, mezzanine equity, and equity Current liabilities Accounts payable and accrued expenses $ 94,811 $ 59,949 Fiduciary accounts payable 6,041 7,737 Medical liabilities 160,279 106,657 Dividend payable 638 638 Finance lease liabilities 554 646 Operating lease liabilities 5,241 4,607 Current portion of long-term debt 15,000 19,500 Other liabilities 30,364 18,940 Total current liabilities 312,928 218,674 Non-current liabilities Deferred tax liability 2,857 4,072 Finance lease liabilities, net of current portion 743 1,033 Operating lease liabilities, net of current portion 31,162 36,289 Long-term debt, net of current portion and deferred financing costs 423,119 258,939 Other long-t

View Full Filing

View this 10-Q filing on SEC EDGAR